CME
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era
November 09, 2020
Host: Karen Reckamp, MS, MD
Host: Heather Wakelee, MD
Because of advances in the understanding of molecular-driven pathways in non–small cell lung cancer (NSCLC) and the availability of targeted therapies and immunotherapy, the treatment landscape
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!